
Insurance can better cataract surgery outcomes for India's elderly: study
The team's findings were published in the August edition of The Lancet Regional Health - Southeast Asia.
The researchers mined an electronic medical record system linking every level of the institute's network across Andhra Pradesh, Karnataka, Odisha, and Telangana. They pulled all first‑eye cataract operations performed on patients aged 70-100 years between August 2011 and December 2022. They discarded engagements that were charity‑funded and focused on people who had to choose a payment method.
For each of these 38,387 surgeries, they logged gender, age, place of residence, self‑reported socioeconomic class, systemic illnesses, payment mode (out of pocket or insurance), and, if insured, whether the policy was a government scheme or a private plan.
They also recorded the gap between the day surgery was advised and the day it was done. They also graded uncorrected visual acuity three to six weeks after surgery as 'good', 'normal' or 'poor' following World Health Organisation standards.
Upon analysing the data, the researchers found that insurance was rare and fell off with age. Only 16% of all patients used any insurance. The uptake slid from 17.5% in the 70-74 years band to under 10% after age 85, largely because private insurers stop offering or become too costly. The public schemes were stuck at 3-4% in every age band.
According to the study, after the national launch of the Ayushman Bharat programme and other State schemes ramped up in 2018, overall coverage for cataract surgery jumped to 20.6%, nearly twice the 10.7% in 2011‑2017. According to the team, this policy shift was the single strongest predictor of anyone having insurance.
They also reported that elderly men insured themselves 19% of the time versus only 12% for women. Similarly, people from rural districts were less likely to be covered than residents of metros and that uptake rose steadily with socioeconomic class.
Uninsured patients had surgery a median six days after advice. Those with private insurance waited 11 days and those on government schemes endured an 18‑day median delay, due to the paperwork and approval time. However, after controlling for every other factor, having any insurance made a patient 38% more likely to end up with 'good' uncorrected vision. Among people over 80, those without insurance were noticeably more likely to leave surgery till seeing poorly.
In sum, cataract surgery was widely available yet the elders who needed it most often lacked insurance and were more likely to come out with worse eyesight.
'This study is powerful evidence that adequate insurance coverage improves the chances of receiving timely health care while also benefiting from superior outcomes. I would argue that these findings are true not just for cataract surgery, but for all forms of health intervention,' Brijesh Takkar, consultant ophthalmologist at the institute and the first author of the study, said. 'Our national health policy should insure the many who are vulnerable to financial insecurity. This has the potential to reduce the burden of healthcare costs on them.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
an hour ago
- Time of India
Did you know Niacinamide can calm seasonal skin flare-ups?
Seasonal weather changes often trigger skin flare-ups, but niacinamide, or Vitamin B3, offers a soothing solution. Dermatologists recommend this multi-functional ingredient for its anti-inflammatory and barrier-strengthening properties. Niacinamide calms redness, regulates oil production, and improves skin tone. Experts suggest using serums or moisturizers with 5% to 10% concentration, especially in sunscreens, to combat tanning and pigmentation common in Indian skin. Seasonal transitions can often wreak havoc on our skin. Whether it's the humidity of monsoon, the dryness of winter, or the pollutants that come with changing weather patterns, our skin is constantly adapting, and not always happily. Flare-ups such as redness, irritation, breakouts, and uneven tones become more frequent. Enter niacinamide, a skincare ingredient that's increasingly being recommended by dermatologists for its calming and strengthening properties. It deserves a permanent place in your skincare routine, especially during seasonal shifts. Why Does Skin Flare Up with Weather Changes? Seasonal changes disrupt the skin's natural barrier. Humidity, heat, or a sudden drop in temperature can affect how our skin retains moisture or reacts to external irritants. This can lead to inflammation, dullness, sensitivity, or increased oil production- all of which we refer to as flare-ups. What Is Niacinamide and How Niacinamide Helps Calm Flare-Ups Niacinamide, also known as Vitamin B3, is a multi-functional skincare ingredient known for its anti-inflammatory, barrier-strengthening, and oil-regulating properties. It is suitable for almost all skin types and is especially beneficial during times of transition when skin becomes unpredictable. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Discover Effortless Glucose Monitoring: Request a Free Trial Dexcom Click Here Undo Here's how it helps calm flare-ups: 1. Soothes Inflammation: Niacinamide has proven anti-inflammatory effects. This makes it extremely useful in calming redness, irritation, and sensitivity, which are common during seasonal transitions. 2. Strengthens Skin Barrier: A healthy skin barrier is your first defense against environmental stressors. Niacinamide boosts the production of ceramides - lipid molecules that keep the skin barrier intact, thus improving resilience. 3. Regulates Oil Production: During monsoon or humid months, many people struggle with excessive oiliness and breakouts. Niacinamide helps balance sebum levels, reducing the chances of clogged pores and acne. 4. Improves Skin Tone and Texture: Flare-ups can often leave behind marks or pigmentation. Niacinamide helps fade dark spots and promotes a more even skin tone over time. How to Use It Dr. Aparna recommends looking for serums or moisturisers with 5% to 10% niacinamide. 'Start with a lower concentration if you have sensitive skin and always patch tests before full use. It can be used both morning and night and goes well with ingredients like hyaluronic acid and ceramides. Indian skin is more prone to tanning and pigmentation due to its higher melanin content. This makes niacinamide an essential ingredient in sunscreen formulations. Known to regulate melanin production and strengthen the skin barrier, niacinamide not only helps reduce tanning but also addresses uneven skin tone - concerns that affect most Indian women. By including niacinamide, sunscreens go beyond basic protection, offering targeted care tailored to the specific needs of Indian skin.' A Word of Caution While niacinamide is generally well-tolerated, overuse or layering it incorrectly can cause mild irritation. 'More is not always better,' warns Dr. Santhanam. 'Stick to the recommended dosage and avoid using it alongside too many actives like AHAs or retinol unless advised by a dermatologist.' Seasonal flare-ups may be inevitable, but with the right ingredients, they can be managed effectively. Niacinamide stands out as a versatile and gentle option that not only soothes the skin but also helps it adapt and thrive through changing conditions. If you're looking to add one product to your monsoon or winter routine, niacinamide could be the skin savior you didn't know you needed. Inputs by Dr. Aparna Santhanam, Dermatologist and Skin Expert at ITC Dermafique


Hindustan Times
an hour ago
- Hindustan Times
Employee suffers ‘massive heart attack', blames toxic Indian startup: ‘Gaslighting, nepotism, zero respect'
An employee in a Reddit post claimed that the toxic work culture at an Indian startup resulted in the worker suffering a massive heart attack and ending up jobless with an uncertain future. The individual wrote that despite noticing red flags in the job, the worker was forced to work for 'megalomaniac founders' due to the brutal job market. An employee blamed a toxic Indian startup after suffering a heart attack. (Representative image). (Unsplash/elimendeinagella) 'Here's my story - two decades working with US/European companies taught me what healthy work culture looks like. Last year, I ignored every red flag and joined an Indian startup as I had no other options after being laid off,' the employee wrote, adding, 'The signs were there from week two- fudged revenue numbers, megalomaniac founders, 'always-on' expectations from 11:30am to 2am daily. Classic toxic Indian workplace - gaslighting, nepotism, impossible clients, zero respect.' In the following few lines, the employee claimed that the daily pressure of work and the disrespect at the workplace 'chipped away' at their 'sanity, ethics, and self-respect.' The person continued, 'Depression crept in as the founders' failures made them increasingly abusive to employees.' Unable to endure more, the employee finally resigned, but within a few weeks, suffered a massive heart attack. 'Within a few weeks: massive heart attack. Two emergency stents. Doctors said 30 minutes more would've been fatal." "Now I'm home - jobless, damaged heart, uncertain future. Was that monthly salary worth permanently destroying my health? Hell no.' The individual concluded the post by saying, 'there's always a choice,' urging others not to suffer at a toxic workplace 'for financial security.' How did social media react? The post prompted a flurry of responses. Many shared similar stories of their own. An individual posted, 'I can understand ...I am in the same boat, but not me, my husband got two heart attacks, three stents, at the age of 31. He was made to sit at home, so I left my job for caregiving. It's not just in IT but in every field. He's in the hotel industry. Joining back is still a stressful job, and every visit to the doctor is still a nightmare with new issues.' Another added, 'Get well soon. You certainly did not deserve the disrespect and mental torture. But it's a great lesson to get away from egotistical founders who think they are the gangsters of the business world. I worked at one such firm, and my health went downhill.' A third expressed, 'I'm so sorry this happened to you. Please take care of your health. I guess these startups don't even provide health insurance and annual preventive health checkups.' The OP responded, 'They provided health insurance like most others. But they should have created an environment where no employees would ever have to use them.' A fourth wrote, 'Even though I agree with you and hate the toxic culture, I know there are people living paycheck to paycheck, so it doesn't matter how bad the environment is; they can't leave unless they have other options. I understand your point that the family needs them alive. Still, working men are the only earners in many families, so it's more like a responsibility to keep working to provide for their spouse, children, parents, and siblings. I am not saying I disagree, but unfortunately, the reality of life is sometimes bigger than any right or wrong.'


Time of India
5 hours ago
- Time of India
A new drug may reduce brain damage from stroke by 60%
Globally, strokes affect 15 million individuals annually, resulting in 5 million deaths and leaving another 5 million with permanent disabilities. Recognizing the severe consequences of stroke, scientists have developed a promising new drug. This innovative treatment aims to significantly minimize brain damage caused by strokes, potentially improving patient outcomes and quality of life. 15 million people suffer a stroke every year worldwide, according to the World Health Organisation( WHO ). Of these, 5 million die, while another 5 million are left permanently disabled. What makes a stroke exceptionally dangerous, is that it could either be fatal or leave the person disabled. The latter significantly reduces the quality of life. Scientists have now developed a new drug that may significantly reduce brain damage caused by strokes. Yes, that's right! Scientists from the University of Cambridge have developed a drug that can reduce brain damage caused by strokes by 60%. The findings of the study is published in Cardiovascular Research . What is a stroke A stroke occurs when blood flow to the brain is blocked or there is sudden bleeding in the brain. There are two types of strokes. Ischemic stroke Hemorrhagic stroke Ischemic stroke is a stroke that occurs when the blood flow to the brain is blocked. Hemorrhagic strokes are those that occur when a blood vessel ruptures and bleeds into the brain. Ischemic stroke is the most common type, accounting for approximately 87% of all strokes. A stroke can be either fatal or leave devastating consequences. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Mini House for 60 sqm for Seniors with Toilet and Bath (Price May Surprise You) Pre Fabricated Homes | Search Ads Search Now Undo As many as one in four people will have a stroke during their lifetime. The first few hours following a stroke are crucial. This is the time when the blood clot needs to be removed quickly so that the oxygen supply to the brain can be restored; otherwise, the brain tissue begins to die. At present, the gold standard treatment is mechanical thrombectomy. However, the outcomes are still poor, with fewer than one in 10 patients leaving the hospital with no neurological impairment. New drug offers a promise to reduce the brain damage in stroke survivors (Pic courtesy: iStock) The Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when blood flow is restored following a stroke . 'Stroke is a devastating disease. Even for those who survive, there is a significant risk of damage to the brain that can lead to disabilities and a huge impact on an individual's life. But in terms of treatment, once the stroke is happening, we have only limited options,' Professor Thomas Krieg from the Department of Medicine at the University of Cambridge said in a statement. Mechanical thrombectomy is a minimally invasive medical procedure where a thin tube, known as a catheter, is inserted into the blood vessel, often through the groin or arm. This is guided to the blood clot, where it is removed by a tiny device, restoring normal blood flow. However, restoring the blood flow too quickly could also backfire. This is called ischaemia-reperfusion injury, where blood rushes back into the oxygen-starved tissue (a process known as reperfusion), the damaged cells struggle to cope, leading to the production of harmful molecules called free radicals that can damage cells, proteins, and DNA. This triggers further damage and can cause an inflammatory response. A previous study by the Cambridge team showed that when the brain is starved of oxygen, it lead to the build-up of a chemical called succinate. When blood flow is restored, the succinate is rapidly oxidised to drive free radical production within mitochondria, the 'batteries' that power our cells, initiating the extra damage. This occurs within the first few minutes of reperfusion, but the researchers showed that the oxidation of succinate can be blocked by the molecule malonate. 'All of this happens very rapidly, but if we can get malonate in quickly at the start of reperfusion, we can prevent this oxidation and burst of free radicals. We discovered in our labs that we can get malonate into cells very quickly by lowering the pH a little, making it a bit more acidic, so that it can cross the blood-brain barrier better. If we inject it into the brain just as we're ready to reperfuse, then we can potentially prevent further damage,' Professor Mike Murphy from the Medical Research Council Mitochondrial Biology Unit said. The findings The new study found that treating the brain with a form of the chemical known as acidified disodium malonate (aDSM) alongside mechanical thrombectomy greatly decreased the amount of brain damage that occurs from ischaemia-reperfusion injury by as much as 60%. The researchers developed a mouse model that mimics mechanical thrombectomy, allowing the team to test the effectiveness of aDSM against ischaemia-reperfusion injury. 'This approach reduces the amount of dead brain tissue resulting from a stroke. This is incredibly important because the amount of dead brain tissue is directly correlated to the patient's recovery, to their disability, whether they can still use all their limbs, speak, and understand language, for example,' Dr Jordan Lee, a postdoctoral researcher in the group, and the one behind the mouse model, said. No more guesswork: Doctor busts common myths about women's health The researchers are now hoping to start early-stage clinical trials. 'If it's successful, this same drug could have much wider applications for other instances of ischemia-reperfusion injuries, such as heart attack, resuscitation, organ transplantation, and so on, which have similar underlying mechanisms,' Professor Murphy added.